Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 2
1966 11
1967 11
1968 14
1969 10
1970 7
1971 15
1972 16
1973 18
1974 13
1975 9
1976 14
1977 13
1978 15
1979 9
1980 11
1981 9
1982 7
1983 11
1984 11
1985 14
1986 8
1987 10
1988 4
1989 20
1990 7
1991 9
1992 6
1993 6
1994 11
1995 9
1996 14
1997 15
1998 17
1999 13
2000 17
2001 17
2002 11
2003 17
2004 9
2005 17
2006 16
2007 22
2008 26
2009 20
2010 26
2011 31
2012 34
2013 33
2014 26
2015 16
2016 20
2017 15
2018 13
2019 14
2020 14
2021 9
2022 9
2023 9
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

776 results

Results by year

Filters applied: . Clear all
Page 1
Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial.
Trotti LM, Blake T, Hoque R, Rye DB, Sharma S, Bliwise DL. Trotti LM, et al. CNS Drugs. 2024 Nov;38(11):909-920. doi: 10.1007/s40263-024-01122-y. Epub 2024 Sep 21. CNS Drugs. 2024. PMID: 39306601 Clinical Trial.
We performed a randomized, fully blinded, noninferiority trial of modafinil versus amphetamine-dextroamphetamine in these disorders. METHODS: Forty-four adults were randomized to modafinil or amphetamine-dextroamphetamine, individually titrated to a maximum of modaf …
We performed a randomized, fully blinded, noninferiority trial of modafinil versus amphetamine-dextroamphetamine in these disorders. …
Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
Ramtvedt BE, Røinås E, Aabech HS, Sundet KS. Ramtvedt BE, et al. J Child Adolesc Psychopharmacol. 2013 Nov;23(9):597-604. doi: 10.1089/cap.2012.0085. Epub 2013 May 9. J Child Adolesc Psychopharmacol. 2013. PMID: 23659360 Free PMC article. Clinical Trial.
OBJECTIVE: The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. METHOD: Thirty-six medication-naive children ages 9-14 years diagnosed with attention-deficit/hyperactivity disorder (ADHD) …
OBJECTIVE: The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in s …
Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
Goldstein LB, Lennihan L, Rabadi MJ, Good DC, Reding MJ, Dromerick AW, Samsa GP, Pura J. Goldstein LB, et al. JAMA Neurol. 2018 Dec 1;75(12):1494-1501. doi: 10.1001/jamaneurol.2018.2338. JAMA Neurol. 2018. PMID: 30167675 Free PMC article. Clinical Trial.
IMPORTANCE: Data from animal models show that the administration of dextroamphetamine combined with task-relevant training facilitates recovery after focal brain injury. ...RESULTS: Among the 64 patients randomized to dextroamphetamine vs placebo (55% men; median ag …
IMPORTANCE: Data from animal models show that the administration of dextroamphetamine combined with task-relevant training facilitate …
Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE, Aabech HS, Sundet K. Ramtvedt BE, et al. J Child Adolesc Psychopharmacol. 2014 Apr;24(3):130-9. doi: 10.1089/cap.2013.0114. Epub 2014 Mar 25. J Child Adolesc Psychopharmacol. 2014. PMID: 24666268 Free PMC article. Clinical Trial.
No significant increase from placebo to stimulant conditions was detected on SERS items reflecting emotional symptoms. Furthermore, dextroamphetamine and methylphenidate did not differ from each other on any SERS item, except that dextroamphetamine was associated wi …
No significant increase from placebo to stimulant conditions was detected on SERS items reflecting emotional symptoms. Furthermore, dextr …
d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial.
Cutler AJ, Suzuki K, Starling B, Balakrishnan K, Komaroff M, Meeves S, Castelli M, Childress A. Cutler AJ, et al. J Child Adolesc Psychopharmacol. 2023 Jun;33(5):176-182. doi: 10.1089/cap.2023.0005. J Child Adolesc Psychopharmacol. 2023. PMID: 37339441 Free PMC article. Clinical Trial.
Objectives: Amphetamines are a preferred treatment for attention-deficit/hyperactivity disorder (ADHD), with the dextroamphetamine transdermal system (d-ATS) providing an alternative to oral formulations. ...
Objectives: Amphetamines are a preferred treatment for attention-deficit/hyperactivity disorder (ADHD), with the dextroamphetamine tr …
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
Weiss M, Hechtman L; Adult ADHD Research Group. Weiss M, et al. J Clin Psychiatry. 2006 Apr;67(4):611-9. J Clin Psychiatry. 2006. PMID: 16669726 Clinical Trial.
METHOD: Ninety-eight adults with DSM-IV ADHD were randomly assigned to receive psychotherapy and dextroamphetamine, paroxetine, both, or placebo for 20 weeks. A 2 x 2 factorial design compared patients who received dextroamphetamine versus no dextroamphetamine …
METHOD: Ninety-eight adults with DSM-IV ADHD were randomly assigned to receive psychotherapy and dextroamphetamine, paroxetine, both, …
Amphetamine abuse.
Ellinwood EH, Cohen S. Ellinwood EH, et al. Science. 1971 Jan 29;171(3969):420-1. doi: 10.1126/science.171.3969.420. Science. 1971. PMID: 4923360 Clinical Trial. No abstract available.
Neurobiological basis of reinforcement-based decision making in adults with ADHD treated with lisdexamfetamine dimesylate: Preliminary findings and implications for mechanisms influencing clinical improvement.
Newcorn JH, Ivanov I, Krone B, Li X, Duhoux S, White S, Schulz KP, Bédard AV, Pedraza J, Adler L, Blair RJ. Newcorn JH, et al. J Psychiatr Res. 2024 Feb;170:19-26. doi: 10.1016/j.jpsychires.2023.11.037. Epub 2023 Dec 3. J Psychiatr Res. 2024. PMID: 38101205 Clinical Trial.
Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study.
Cutler AJ, Suzuki K, Starling B, Balakrishnan K, Komaroff M, Castelli M, Meeves S, Childress AC. Cutler AJ, et al. J Child Adolesc Psychopharmacol. 2022 Mar;32(2):89-97. doi: 10.1089/cap.2021.0107. Epub 2022 Jan 11. J Child Adolesc Psychopharmacol. 2022. PMID: 35020462 Free PMC article. Clinical Trial.
Objectives: To assess efficacy and safety of the new Dextroamphetamine Transdermal System (d-ATS) to treat children and adolescents (aged 6-17 years) with attention-deficit/hyperactivity disorder (ADHD). ...
Objectives: To assess efficacy and safety of the new Dextroamphetamine Transdermal System (d-ATS) to treat children and adolescents ( …
776 results